Brief: Bluebird Bio Announces Completion Of First Cell Collection For Lyfgenia Gene Therapy
06/05/2024 12:38
May 6 (Reuters) - bluebird bio Inc BLUE.O :
* BLUEBIRD BIO ANNOUNCES COMPLETION OF FIRST CELL COLLECTION
FOR
LYFGENIA™ GENE THERAPY
Source text for Eikon: ID:nBw2bNrYwa
Further company coverage: BLUE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on bluebird bio
See all newsBrief: Bluebird Bio Announces Completion Of Acquisition By Carlyle And SK Capital
Brief: Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer
Brief: Carlyle, SK Capital Partners And Bluebird Bio Provide Updated Tender Instructions
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera Investment